Cardiovascular effects of angiotensin A: A novel peptide of the renin-angiotensin system

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 4, 2014, Pages 480-486

  Coutinho, Danielle C O ^a   Foureaux, Giselle ^a   Rodrigues, Keyla D L ^a   Salles, Rodrigo L A ^a   Moraes, Patrícia L ^a   Murça, Tatiane M ^a   De Maria, Marilda L A ^a   Gomes, Enéas R M ^a   Santos, Robson A S ^a   Guatimosim, Sílvia ^a   Ferreira, Anderson J ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin II; angiotensin converting enzyme inhibitors; AT1 receptor blockers; blood pressure; calcium handling; cardiac function

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN A; CALCIUM; LOSARTAN; UNCLASSIFIED DRUG; ANGIOTENSIN DERIVATIVE; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; HEART FUNCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; MALE; NONHUMAN; PRESSOR RESPONSE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CALCIUM SIGNALING; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; HEART; HEART FUNCTION TEST; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REPERFUSION INJURY; WISTAR RAT;

ANGIOTENSINS; ANIMALS; BLOOD PRESSURE; CALCIUM SIGNALING; CARDIOVASCULAR SYSTEM; HEART; HEART FUNCTION TESTS; HUMANS; IN VITRO TECHNIQUES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PEPTIDES; RATS, WISTAR; RENIN-ANGIOTENSIN SYSTEM;

EID: 84918509825     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312474856     Document Type: Article

References (23)

1. Members WG, Roger VL, Go AS, et al. Executive summary: Heart disease and stroke statistics-2011 update. Circulation. 2011 ; 123: 459-463
2. Inagami T. A memorial to Robert Tiegerstedt: The centennial of renin discovery. Hypertension. 1998 ; 32: 953-957
3. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res. 2002 ; 35: 1001-1015
4. Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000 ; 52: 415-472
5. Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol. 1997 ; 59: 395-412
6. Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens. 2000 ; 13: 31S - 38S
7. Paz Y, Gurevitch J, Frolkis I, et al. Effects of an angiotensin II antagonist on ischemic and nonischemic isolated rat hearts. Ann Thorac Surg. 1998 ; 65: 474-479
8. Ozer MK, Sahna E, Birincioglu M, et al. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats. Pharmacol Res. 2002 ; 45: 257-263
9. Yang BC, Phillips MI, Ambuehl PEJ, et al. Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts. Circulation. 1997 ; 96: 922-926
10. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997 ; 349: 747-752
11. Chappell MC, Iyer SN, Diz DI, et al. Antihypertensive effects of angiotensin-(1-7). Braz J Med Biol Res. 1998 ; 31: 1205-1212
12. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension. 1998 ; 31: 356-361
13. Ishiyama Y, Gallagher PE, Averill DB, et al. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004 ; 43: 970-976
14. Ferreira AJ, Jacoby BA, Araujo CA, et al. The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. Am J Physiol Heart Circ Physiol. 2007 ; 292: H1113 - H1119
15. Jankowski V, Vanholder R, van der Giet M, et al. Mass- spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol. 2007 ; 27: 297-302
16. Yang R, Smolders I, Vanderheyden P, et al. Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent. Hypertension. 2011 ; 57: 956-964
17. Ferreira AJ, Santos RAS, Almeida AP. Angiotensin-(1-7): Cardioprotective effect in myocardial ischemia/reperfusion. Hypertension. 2001 ; 38: 665-668
18. Neves LA, Almeida AP, Khosla MC, et al. Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Braz J Med Biol Res. 1997 ; 30: 801-809
19. Roman-Campos D, Duarte HL, Gomes ER, et al. Investigation of the cardiomyocyte dysfunction in bradykinin type 2 receptor knockout mice. Life Sci. 2010 ; 87: 715-723
20. Cumming DV, Heads RJ, Brand NJ, et al. The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes. Basic Res Cardiol. 1996 ; 91: 79-85
21. Louch WE, Ferrier GR, Howlett SE. Losartan improves recovery of contraction and inhibits transient inward current in a cellular model of cardiac ischemia and reperfusion. J Pharmacol Exp Ther. 2000 ; 295: 697-704
22. Good JM, Nihoyannopoulos P, Ghatei MA, et al. Elevated plasma endothelin concentrations in heart failure: An effect of angiotensin II?. Eur Heart J. 1994 ; 15: 1634-1640
23. Sigurdsson A, Held P, Swedberg K. Short-and long-term neurohormonal activation following acute myocardial infarction. Am Heart J. 1993 ; 126: 1068-1076